Picture of Medesis Pharma SA logo

ALMDP Medesis Pharma SA Income Statement

0.000.00%
fr flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Annual income statement for Medesis Pharma SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

2018
December 31st
2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:PROSPECTUSPROSPECTUSARSARSARS
Standards:
FAS
FAS
FAS
FAS
FAS
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue0.010.20.20.0730
Cost of Revenue
Gross Profit0.0050.1940.1730.056-0.042
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses1.211.841.133.293.23
Operating Profit-1.2-1.64-0.932-3.21-3.23
Total Net Non Operating Interest Income / Expense
Net Income Before Taxes-1.24-2.08-0.991-3.21-3.23
Provision for Income Taxes
Net Income After Taxes-1.02-1.93-0.791-2.65-2.75
Net Income Before Extraordinary Items
Net Income-1.02-1.93-0.791-2.65-2.75
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income-1.02-1.93-0.791-2.65-2.75
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS-0.235-0.316-0.19-0.606-0.628
Dividends per Share